Trial Profile
Long-term Surveillance Registry for Biologics (HUMIRA).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms HUMIRA
- Sponsors Abbott Laboratories; AbbVie
- 01 May 2020 Results (n=2654) of a retrospective and a sub-group analysis from two large observational studies: NCT01077258 and NCT01078090 assessing whether previous biologic therapy influenced the impact of concomitant Methotrexate in patients initiating treatment with adalimumab during routine clinical practice published in the Medicine
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2012 Planned number of patients changed from 5738 to 5742.